1. Home
  2. MDXG vs IGIC Comparison

MDXG vs IGIC Comparison

Compare MDXG & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • IGIC
  • Stock Information
  • Founded
  • MDXG 2006
  • IGIC 2001
  • Country
  • MDXG United States
  • IGIC Jordan
  • Employees
  • MDXG N/A
  • IGIC N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • IGIC Property-Casualty Insurers
  • Sector
  • MDXG Health Care
  • IGIC Finance
  • Exchange
  • MDXG Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • MDXG 1.1B
  • IGIC 1.0B
  • IPO Year
  • MDXG N/A
  • IGIC N/A
  • Fundamental
  • Price
  • MDXG $6.94
  • IGIC $23.61
  • Analyst Decision
  • MDXG Buy
  • IGIC Buy
  • Analyst Count
  • MDXG 1
  • IGIC 2
  • Target Price
  • MDXG $12.00
  • IGIC $31.50
  • AVG Volume (30 Days)
  • MDXG 439.7K
  • IGIC 67.3K
  • Earning Date
  • MDXG 10-29-2025
  • IGIC 11-04-2025
  • Dividend Yield
  • MDXG N/A
  • IGIC 0.42%
  • EPS Growth
  • MDXG N/A
  • IGIC 11.00
  • EPS
  • MDXG 0.21
  • IGIC 2.79
  • Revenue
  • MDXG $363,774,000.00
  • IGIC $535,109,000.00
  • Revenue This Year
  • MDXG $12.68
  • IGIC $6.05
  • Revenue Next Year
  • MDXG $8.18
  • IGIC $7.01
  • P/E Ratio
  • MDXG $32.78
  • IGIC $8.67
  • Revenue Growth
  • MDXG 6.85
  • IGIC 9.99
  • 52 Week Low
  • MDXG $5.47
  • IGIC $18.11
  • 52 Week High
  • MDXG $10.14
  • IGIC $27.76
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.17
  • IGIC 41.95
  • Support Level
  • MDXG $6.89
  • IGIC $23.81
  • Resistance Level
  • MDXG $7.14
  • IGIC $24.94
  • Average True Range (ATR)
  • MDXG 0.18
  • IGIC 0.51
  • MACD
  • MDXG -0.04
  • IGIC -0.06
  • Stochastic Oscillator
  • MDXG 29.55
  • IGIC 4.31

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: